Results
|
181.
|
|
|
182.
|
|
|
183.
|
|
|
184.
|
|
|
185.
|
|
|
186.
|
|
|
187.
|
|
|
188.
|
Improved endpoints for cancer immunotherapy trials. [electronic resource] by
- Hoos, Axel
- Eggermont, Alexander M M
- Janetzki, Sylvia
- Hodi, F Stephen
- Ibrahim, Ramy
- Anderson, Aparna
- Humphrey, Rachel
- Blumenstein, Brent
- Old, Lloyd
- Wolchok, Jedd
Producer: 20101004
In:
Journal of the National Cancer Institute vol. 102
Availability: No items available.
|
|
189.
|
Prognostic and predictive value of YKL-40 in stage IIB-III melanoma. [electronic resource] by
- Krogh, Merete
- Christensen, Ib
- Bouwhuis, Marna
- Johansen, Julia S
- Nørgaard, Peter
- Schmidt, Henrik
- Hansson, Johan
- Suciu, Stefan
- Eggermont, Alexander M M
- Bastholt, Lars
Producer: 20180214
In:
Melanoma research vol. 26
Availability: No items available.
|
|
190.
|
|
|
191.
|
|
|
192.
|
|
|
193.
|
|
|
194.
|
|
|
195.
|
A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein. [electronic resource] by
- Zhang, Yi
- Chaux, Pascal
- Stroobant, Vincent
- Eggermont, Alexander M M
- Corthals, Jurgen
- Maillère, Bernard
- Thielemans, Kris
- Marchand, Marie
- Boon, Thierry
- Van Der Bruggen, Pierre
Producer: 20030922
In:
Journal of immunology (Baltimore, Md. : 1950) vol. 171
Availability: No items available.
|
|
196.
|
|
|
197.
|
|
|
198.
|
|
|
199.
|
|
|
200.
|
|